Concourse Financial Group Securities’s VanEck Pharmaceutical ETF PPH Stock Holding History

Concourse Financial Group Securities’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500	Closed	-$32K	–	2348
2020 Q3	$31K	Hold	500	–	–	﹤0.01%	1224
2020 Q2	$31K	Hold	500	–	–	﹤0.01%	1133
2020 Q1	$27K	Hold	500	–	–	﹤0.01%	1125
2019 Q4	$32K	Hold	500	–	–	﹤0.01%	1105
2019 Q3	$28K	Sell	500 -2,090	-81%	-$120K	0.01%	834
2019 Q2	$152K	Buy	2,590 +45	+2%	+$2.6K	0.02%	548
2019 Q1	$154K	Buy	2,545 +2,045	+409%	+$121K	0.02%	565
2018 Q4	$27K	Hold	500	–	–	﹤0.01%	1021
2018 Q3	$32K	Buy	+500	New	+$31.2K	0.01%	698

Other funds holding PPH

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

22CM

20/20 Capital Management Costa Mesa, California $386M AUM 30.28% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Concourse Financial Group Securities's PPH Position: Q4 2020 in Review

Concourse Financial Group Securities sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2020, closing a stake of 500 shares — an estimated $32K sold.

Concourse Financial Group Securities first reported a position in PPH in Q3 2018 and held it in 9 quarters. The position peaked at $154K in Q1 2019. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2020.

Concourse Financial Group Securities reported no remaining VanEck Pharmaceutical ETF position as of Q4 2020 after selling out during the quarter.
Concourse Financial Group Securities sold 500 VanEck Pharmaceutical ETF shares in Q4 2020, an estimated $32K.
Concourse Financial Group Securities first reported a position in VanEck Pharmaceutical ETF in Q3 2018 and held it in 9 quarters.
Concourse Financial Group Securities's VanEck Pharmaceutical ETF position peaked at $154K in Q1 2019.
49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2020.

Based on Concourse Financial Group Securities's 13F filing for Q4 2020, filed 2 Feb 2021.